| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2003 | WO2003059350A1 Development of novel regulators of angiogenesis |
| 07/24/2003 | WO2003059349A1 Sedative non-benzodiazepine formulations |
| 07/24/2003 | WO2003059348A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 07/24/2003 | WO2003059347A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
| 07/24/2003 | WO2003059346A1 Beta-secretase inhibitors |
| 07/24/2003 | WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 07/24/2003 | WO2003059344A1 Suppositories containing indole derivative |
| 07/24/2003 | WO2003059343A2 Drug compositions with indole alkaloids for the treatment of aids |
| 07/24/2003 | WO2003059342A1 Histamine-3 receptor ligands for diabetic conditions |
| 07/24/2003 | WO2003059340A1 Method for the preparation of lariciresinol, cyclolariciresinol and secoisolariciresinol |
| 07/24/2003 | WO2003059338A1 Process for producing liquid preparation containing branched amino acids |
| 07/24/2003 | WO2003059337A1 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid |
| 07/24/2003 | WO2003059336A1 Methods for treating eye disorders |
| 07/24/2003 | WO2003059335A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | WO2003059334A2 Gemcitabine in the treatment of smallpox |
| 07/24/2003 | WO2003059332A2 Use of an anti-microtubule agent for the treatment of uveitis |
| 07/24/2003 | WO2003059330A1 Stable pharmaceutical compositions comprising ace inhibitor(s) |
| 07/24/2003 | WO2003059328A1 Formulations |
| 07/24/2003 | WO2003059327A1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 07/24/2003 | WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 07/24/2003 | WO2003059320A1 Composition and method for the treatment of anorectal disorders |
| 07/24/2003 | WO2003059309A1 Composition based on 5,7 dmc and/or bergamottin |
| 07/24/2003 | WO2003059297A2 Dermatological topical compositions and a process for the preparation thereof |
| 07/24/2003 | WO2003059296A2 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | WO2003059293A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/24/2003 | WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 07/24/2003 | WO2003059288A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 07/24/2003 | WO2003059283A2 Compounds for blocking androgen receptors |
| 07/24/2003 | WO2003059277A2 Methods and compositions for stimulating bone growth using inhibitors of microtubule assembly |
| 07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | WO2003059274A2 Vitamin formulation for cardiovascular health |
| 07/24/2003 | WO2003059271A2 Treatment involving peroxisome proliferator-activated receptor-gamma agonist and cyclooxygenase-2 selective inhibitors |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003059267A2 SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF |
| 07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003059258A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003059255A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 07/24/2003 | WO2003059254A2 Prevention and treatment of atherosclerosis and restenosis |
| 07/24/2003 | WO2003059249A2 Nivalenol as specific inhibitor to transcriptional factor c-maf and pharmaceutical compositions comprising the same |
| 07/24/2003 | WO2003059246A2 Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections |
| 07/24/2003 | WO2003059197A2 The use of sulfonated compounds as a barrier contraceptive |
| 07/24/2003 | WO2003059194A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 07/24/2003 | WO2003059193A2 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 07/24/2003 | WO2003059088A1 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 07/24/2003 | WO2003048168A3 Trioxane derivatives as antimalaria or anticancer compounds |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 07/24/2003 | WO2003045332A3 Methods and compositions for treating lesions of the respiratory epithelium |
| 07/24/2003 | WO2003043573A3 Xanthine oxidase inhibition |
| 07/24/2003 | WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 07/24/2003 | WO2003041646A3 L-dopa ethyl ester salts and uses thereof |
| 07/24/2003 | WO2003041645A3 Method of vaccinating a human patient to prevent metastatic tumors |
| 07/24/2003 | WO2003041639A3 Methods and compositions for treating rotavirus-mediated disease |
| 07/24/2003 | WO2003037263A3 Sunspot skin cream |
| 07/24/2003 | WO2003034998A3 Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2003032909A3 Methods of treating skin with diphosphonate derivatives |
| 07/24/2003 | WO2003028713A3 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 07/24/2003 | WO2003028651A3 Antipsychotic agents stimulate neurogenesis in brain |
| 07/24/2003 | WO2003024934A3 Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases |
| 07/24/2003 | WO2003011309A3 Pharmaceutical composition for treating hypercholesterolaemia |
| 07/24/2003 | WO2003009741A3 Methods for treating joint inflammation, pain, and loss of mobility |
| 07/24/2003 | WO2003002528A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/24/2003 | WO2002102369A3 Agent for protection of retinal neurons |
| 07/24/2003 | WO2002099057A3 Sams modifiers of the p53 pathway and methods of use |
| 07/24/2003 | WO2002094179A3 Novel topical microbicidal compositions |
| 07/24/2003 | WO2002078633A3 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia |
| 07/24/2003 | WO2002078523A3 Agent for the treatment of overactive bladder |
| 07/24/2003 | WO2002072104A3 Antihypertensive agent and cholesterol absorption inhibitor combination therapy |
| 07/24/2003 | WO2002067988A3 Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor |
| 07/24/2003 | WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same |
| 07/24/2003 | WO2002049575A3 Method and composition for the treatment of diabetic neuropathy |
| 07/24/2003 | WO2002042272A3 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | WO2002036634A3 Gene regulation therapy involving ferritin |
| 07/24/2003 | WO2002036100A9 Controlled release metformin compositions |
| 07/24/2003 | WO2002019982A3 Cosmetic composition and method for reducing or preventing wrinkling |
| 07/24/2003 | WO2002003979A3 Combination of 2-methoxyestradiol and an agent that increases intracellular superoxide anion |
| 07/24/2003 | US20030139811 Orthopedic hardware with a sustained release device configured to release a compound over an extended period of time and is attachable to a portion of the body |
| 07/24/2003 | US20030139687 Noninvasive measurement of chemical substances |
| 07/24/2003 | US20030139609 Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles |
| 07/24/2003 | US20030139607 Antiarrhythmic agents, treating cardiovascular disorders, infarct prophylaxis, angina pectoris, shock, stroke, transplant organ surgery |
| 07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
| 07/24/2003 | US20030139604 Solid state nuclear magnetic resonance spectrum, phase shifting, infrared spectrum analysis; treating prophylaxis of diabetes mellitus |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139595 Novel process for the fermentative production of cephalosporin |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139583 Process for preparation of anhydrous azithromycin |
| 07/24/2003 | US20030139480 Isolation of cartenoid crystals |
| 07/24/2003 | US20030139477 Dietetics; anticancer agents; antidiabetic agents |
| 07/24/2003 | US20030139476 Method of treating chronic fatigue syndrome |
| 07/24/2003 | US20030139475 Novel tricyclic compounds and drug compositions containing same |
| 07/24/2003 | US20030139472 Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients |
| 07/24/2003 | US20030139471 Compositions which contain triterpenes for regulating hair growth |
| 07/24/2003 | US20030139470 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
| 07/24/2003 | US20030139469 Anticholesterol agents; cardiovascular disorders |